0
Abstract: Poster Presentations |

CENTRAL AIRWAY STABILIZATION FOR PATIENTS WITH MOUNIER-KUHN SYNDROME FREE TO VIEW

Archan M. Shah, MD*; Adnan Majid, MD; Sidharta P. Gangadharan, MD; Saleh Alazemi, MD; David M. Berkowitz, MD; Gaetane C. Michaud, MD; Armin Ernst, MD
Author and Funding Information

Beth Israel Deaconess Medical Center, Boston, MA


Chest


Chest. 2009;136(4_MeetingAbstracts):80S-c-81S. doi:10.1378/chest.08-2823
Text Size: A A A
Published online

Abstract

PURPOSE:  Mounier-Kuhn Syndrome (MKS) is a rare disorder characterized by central airway dilation, diverticulosis and tracheobronchomalacia (TBM). Symptoms include recurrent respiratory infections and bronchiectasis due to ineffective secretion clearance. Our objective is to evaluate effects of airway stenting and/or airway reconstruction surgery as therapeutic options.

METHODS:  Prospective observational study with retrospective review of medical records of consecutive patients with MKS evaluated for TBM. Patients underwent baseline and post intervention assessments of respiratory symptoms, health-related quality of life (HRQOL) and lung function.

RESULTS:  11 men were included (median age 61) were identified. Co-morbidities included COPD (8), bronchiectasis (2) and UIP (1). Symptoms included dyspnea, productive cough and recurrent lower respiratory tract infections and respiratory failure (3). Mean tracheal diameters in the anteroposterior and sagital planes were 26.7 mm and 33.9 mm respectively. Mean right and left bronchial anteroposterior diameters were 20.5 mm and 20.4 mm respectively. All had severe and diffuse TBM. Of the 11 patients: 7 (63%) had a successful stent trial followed by surgery. 1 had surgery without a stent trial and 1 has a permanent stent. 1 elected not to have any intervention and 1 is awaiting surgery.Of 10 patients with airway stabilization, 9 (90%) reported improvement in respiratory symptoms. There was improvement in HRQOL (5 0f 6, 83%), dyspnea scores (4 of 5, 80%), FEV1 (6 of 7, 85%).

CONCLUSION:  Central airway stabilization with silicone stents followed by reconstructive airway surgery is a therapeutic option for patients with MKS, improving respiratory symptoms, dyspnea scores, HRQOL and lung functions.

CLINICAL IMPLICATIONS:  In this largest cohort of patients with MKS, central airway stabilization in an experienced center may improve symptoms.

DISCLOSURE:  Archan Shah, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, November 4, 2009

12:45 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543